Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "governance"

106 News Found

Statement from Krsnaa Diagnostics on IT survey
News | August 02, 2022

Statement from Krsnaa Diagnostics on IT survey

The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.


Essential Pharma progress in its ESG performance
Sustainability | July 20, 2022

Essential Pharma progress in its ESG performance

The company now exceeds the sector benchmark for its overall ESG rating and for all three measures


Piramal Pharma strengthens board by inducting three new board members
People | July 11, 2022

Piramal Pharma strengthens board by inducting three new board members

The appointments will add to the well-diversified experience that currently exists on the PPL board.


PM-JAY public dashboard gets revamped with new features
News | June 07, 2022

PM-JAY public dashboard gets revamped with new features

The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress


Organon introduces global ESG strategy
Sustainability | June 04, 2022

Organon introduces global ESG strategy

Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health


Blockchain improves product authenticity in supply chain, finds GlobalData
Supply Chain | May 30, 2022

Blockchain improves product authenticity in supply chain, finds GlobalData

The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors


Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022
Sustainability | May 25, 2022

Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022

By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry


Pharma companies with ESG more valuable say investors
Sustainability | May 20, 2022

Pharma companies with ESG more valuable say investors

When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’


Driving sustainable, enterprise-wide performance acceleration
Opinion | May 19, 2022

Driving sustainable, enterprise-wide performance acceleration

Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time


Don’t be left short-changed post approval – plan in change orders early for accelerated pathways: Stephanie Gaulding
News | May 19, 2022

Don’t be left short-changed post approval – plan in change orders early for accelerated pathways: Stephanie Gaulding

A post approval change order is often necessary, but innovators should plan and prepare for this pre-approval. Planning alongside outsourcing partners will help ensure that only a small-scale study is needed—not a new full clinical study